Mild Cognitive Impairment (MCI) is a term proposed by Petersen et al.^[@r1]^ to report a clinical syndrome presented by individuals with measurable cognitive deficits who do not fulfill criteria for diagnosis of dementia but who are at high risk of developing it, mainly in the form of Alzheimer's disease (AD).^[@r2]^

The diagnosis of MCI is established based on evidence of cognitive disorder in non-demented individuals who present complaints (preferably corroborated by an informant) in conjunction with objectively measured cognitive deficits, preserved activities of daily living, and intact or minimally impaired complex instrumental functions.^[@r2],[@r3]^

The clinical presentations of MCI can be classified accordingly to three subtypes: amnestic MCI (aMCI), multiple domains (mdMCI) and nonmemory single domain (naMCI single domain) MCI. In aMCI, memory is impaired, but the other cognitive functions can be preserved. On the other hand, mdMCI is characterized by cognitive impairments in other domains such as language, attention, executive functions or visuospatial skills. In these cases, if memory is significantly impaired then this confers aMCI multiple domains, and if not naMCI multiple domains. In the naMCI single domain only one function beyond memory is impaired (e.g. language or visuospatial).^[@r2],[@r3]^

Subjects with MCI can progress to AD or other dementia, remain stable or even recover, although when a person with aMCI has a suspected degenerative disorder this is most likely a case of prodromal AD.^[@r2]-[@r4]^

Data on the prevalence of MCI and the conversion rate to dementia vary widely, depending on the different defining criteria applied^[@r5]^. In a cohort study, Fisher et al.^[@r6]^ compared the conversion rate of the subtypes of MCI to AD in elderly subjects, followed for 30 months. The conversion rates were 48.7% for subjects with aMCI and 28.6% for those with non-amnestic MCI. The rate of conversion to AD among healthy subjects was 12.6%. Visser et al.^[@r7]^ conducted a 10-year follow up study involving subjects with cognitive impairment aged 40 to 85 years to investigate the risk of dementia, and reported rates of conversion of 27% in subjects with cognitive complaints, 28% in subjects with aging-associated cognitive decline, 44% in subjects with mild functional impairment, and 48% in subjects with amnestic MCI.

Controversy exists as to how MCI can be best assessed, as there is insufficient evidence to recommend specific tests^[@r2]^. Petersen et al.^[@r1]^ compared MCI patients, mild AD and controls on a neuropsychological battery and observed that subjects with MCI performed worse than controls, but better than AD patients on memory tasks, and proved more similar to control subjects than to AD patients on measures of general cognition and other nonmemory indexes. In longitudinal studies, delayed recall tests were found to be good predictors of progression to AD^[@r8],[@r9]^, while poor performance in delayed recall and executive function tests indicate a high risk of progression to dementia. Arnaiz and Almkvist^[@r4]^ believe that beyond memory tests, tasks evaluating other cognitive functions such as verbal abilities and learning, visuospatial function, attention and executive functions are important for screening and diagnosis of MCI and early AD.

The aim of this study was to verify differences in performance on neuropsychological tests by controls, aMCI and AD patients.

Methods
=======

In this retrospective study we reviewed 102 medical files of subjects which were divided into three groups: controls (n=60), Alzheimer's disease patients (n=68), and aMCI patients (n=34) ([Table 1](#t1){ref-type="table"}).

###### 

Demographics of the sample.

                         Controls (n=60)           aMCI (n=34)           AD (n=68)   *p*                                                     
  ---------------------- ----------------- ------- ------------- ------- ----------- --------------------------------------- ------- ------- -------------------------------------------
  Gender (female/male)   42/18                     20/14                 40/28       0.364[\*](#TFN1){ref-type="table-fn"}                   
  Age                    68.90             ±7.48                 74.44   ±7.05                                               73.77   ±7.24   \<0.001[\*\*](#TFN2){ref-type="table-fn"}
  Education              10.72             ±4.74                 12.35   ±4.01                                               9.04    ±4.83   0.03[\*\*](#TFN2){ref-type="table-fn"}

Chi-Square Test;

Kruskall-Wallis Test; SD, standard deviation.

All patients were evaluated by members of the Behavioral and Cognitive Neurology Unit of the Department of Neurology at the University of Sao Paulo School of Medicine and from the Center of Cognitive Disorders (CEREDIC) and had been submitted to a general clinical and neurological evaluation and to screening tests comprising the Mini-Mental State Examination (MMSE)^[@r10]^, Brief Cognitive Screening Battery (BCSB),^[@r11],[@r12]^ and Functional Activities Questionnaire.^[@r13],[@r14]^

The patients were classified with mild dementia according to the American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, Third Edition, revised (DSM-III-R)^[@r15]^ criteria and probable AD according to National Institute of Neurological Disorders and Communicative Disorders and Stroke Alzheimer Disease and Related Disorders Association (NINCDS-ADRDA) criteria^[@r16]^. Amnestic MCI patients were diagnosed based on the criteria proposed by Petersen et al.^[@r3],[@r17]^

All patients were also submitted to a comprehensive neuropsychological battery of tests including: executive functions (Trail Making Test versions A and B, Wisconsin Card Sorting Test -- WCST);^[@r18]^ visual perception (Hooper Visual Organization Test,^[@r19]^ Raven's Progressive Matrices^[@r20]^); language (Boston Naming Test,^[@r21],[@r22]^ semantic verbal fluency^[@r18]^); constructive abilities (Block Design, Wechsler Adult Intelligence Scale -- WAIS^[@r23]^, Rey Complex Figure Copy^[@r18],[@r24]^); visual and verbal memory tests (Visual Reproduction of the Wechsler Memory Scale -- Revised - WMS-R,^[@r25]^ Rey Complex Figure -- delayed recall^[@r18],[@r24]^, WMS-R Logical Memory,^[@r25]^ Rey Auditory Verbal Learning Test -- RAVLT^[@r26]^).

Cases of moderate or severe AD, and those presenting other disorders that could affect cognitive functions and non-corrected visual or auditory disorders were excluded.

The control group was composed of 60 volunteers (42 women and 18 men) with no memory or functional disturbances. To be included they had to score above the median values for their educational level on the MMSE,^[@r10]^ below 22 in the Memory Complaint Questionnaire (MAQ-Q)^[@r27]^ and below 3.84 on the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE).^[@r28]^ Subjects with neurological disease, history of alcoholism, depression, or any other psychiatric disorder, non-corrected visual or auditory disorders, motor disorders, or users of psychotropic drugs that could affect cognitive functions were excluded. Chronic diseases such as hypertension, diabetes mellitus and cardiac disorders, if adequately controlled, were not criteria for exclusion.

All patients and control individuals who agreed to participate in the study signed a written informed consent term. This study was approved by the Ethics Committee of the Hospital das Clínicas of the University of São Paulo School of Medicine.

Statistical analysis
--------------------

We used the Chi-square test to evaluate associations between the categorical variables and the results. When the variables were continuous, the comparisons were performed by Mann-Whitney for two samples, and by the Kruskall-Wallis test for more than two samples. The value of significance accepted was 0.01.

All statistical analysis was carried out using the program *Statistical Package for the Social Sciences (SPSS)*, for *Windows*, version 10.0.

Results
=======

No differences related to gender (*p=*0.364) were found among the control group, aMCI and AD patients, but statistically significant differences related to age (*p*\<0.001) and schooling (*p=*0.03) were observed ([Table 1](#t1){ref-type="table"}).

Comparison among controls, aMCI and AD patients on neuropsychological assessments yielded statistically significant differences in all tests applied ([Table 2](#t2){ref-type="table"}).

###### 

Performance of controls, aMCI and AD patients on neuropsychological tests[\*](#TFN3){ref-type="table-fn"}.

  Tests                                     Mean±SD          *p*                               
  ----------------------------------------- ---------------- ---------------- ---------------- ---------
  Hooper                                    54.73 (14.87)    55.60 (17.54)    64.02 (19.75)    0.007
  Block Design (WAIS)                       10.50 (2.75)     11.66 (2.50)     7.10 (3.74)      \<0.001
  Rey Figure - Copy                         30.64 (6.86)     28.20 (6.60)     21.39 (10.18)    \<0.001
  Rey Figure - Memory                       11.02 (7.69)     2.51 (3.21)      0.79 (2.69)      \<0.001
  Trail Making - Part A (Time)              50.81 (31.99)    47.53 (15.23)    92.76 (46.49)    \<0.001
  Trail Making - Part B (Time)              113.72 (52.32)   110.25 (41.75)   215.20 (83.89)   \<0.001
  Logical Memory (WMS-R) - immediate        33.17 (5.51)     26.03 (8.14)     13.78 (8.84)     \<0.001
  Logical Memory (WMS-R) - 30\'             16.94 (8.53)     4.66 (5.33)      1.35 (2.93)      \<0.001
  Visual Reproduction (WMS-R) - immediate   28.82 (8.12)     22.66 (7.57)     14.20 (7.33)     \<0.001
  Visual Reproduction (WMS-R) - 30\'        13.64 (11.81)    1.23 (4.32)      1.01 (3.95)      \<0.001
  RAVLT - total                             40.08 (8.19)     28.60 (7.81)     21.00 (7.91)     \<0.001
  RAVLT - 30\'                              7.55 (3.24)      2.31 (1.74)      1.06 (2.82)      \<0.001
  BNT                                       45.02 (6.85)     42.71 (6.22)     34.28 (8.93)     \<0.001
  WCST (Categories)                         2.12 (1.54)      1.40 (1.34)      0.43 (0.62)      0.001
  Verbal Fluency - supermarket              20.81 (3.74)     18.80 (5.82)     13.49 (4.74)     \<0.001
  Raven\'s Colored Matrices                 26.90 (4.70)     26.50 (3.50)     17.44 (6.22)     \<0.001

Kruskall-Wallis Test; SD, standard deviation; MCI, Mild Cognitive Impairments; WAIS, Wechsler Adult Intelligence Scale; WMS-R, Wechsler Memory Scale - Revised; RAVLT, Rey Auditory Verbal Learning Test; BNT, Boston Naming Test; WCST, Wisconsin Card Sorting Test.

When control group and AD patients were compared, statistically significant differences were found in all tests ([Table 3](#t3){ref-type="table"}).

###### 

Performance of controls and AD patients on the neuropsychological tests[\*](#TFN4){ref-type="table-fn"}.

  Tests                                     Mean±SD          *p*              
  ----------------------------------------- ---------------- ---------------- ---------
  Hooper                                    54.73 (14.87)    64.02 (19.75)    0.004
  Block Design (WAIS)                       10.50 (2.75)     7.10 (3.74)      \<0.001
  Rey Figure - Copy                         30.64 (6.86)     21.39 (10.18)    \<0.001
  Rey Figure - Memory                       11.02 (7.69)     0.79 (2.69)      \<0.001
  Trail Making - Part A (Time)              50.81 (31.99)    92.76 (46.49)    \<0.001
  Trail Making - Part B (Time)              113.72 (52.32)   215.20 (83.89)   \<0.001
  Logical Memory (WMS-R) - immediate        33.17 (5.51)     13.78 (8.84)     \<0.001
  Logical Memory (WMS-R) - 30\'             16.94 (8.53)     1.35 (2.93)      \<0.001
  Visual Reproduction (WMS-R) - immediate   28.82 (8.18)     14.20 (7.33)     \<0.001
  Visual Reproduction (WMS-R) - 30\'        13.64 (11.81)    1.01 (3.95)      \<0.001
  RAVLT - total                             40.08 (8.19)     21.00 (7.91)     \<0.001
  RAVLT - 30\'                              7.55 (3.24)      1.06 (2.82)      \<0.001
  BNT                                       45.02 (6.85)     34.28 (8.93)     \<0.001
  WCST (Categories)                         2.12 (1.54)      0.43 (0.62)      \<0.001
  Verbal Fluency - supermarket              20.81 (3.74)     13.49 (4.74)     \<0.001
  Raven\'s Colored Matrices                 26.90 (4.70)     17.44 (6.22)     \<0.001

Mann-Whitney Test; SD, standard deviation; MCI, Mild Cognitive Impairments; WAIS, Wechsler Adult Intelligence Scale; WMS-R, Wechsler Memory Scale - Revised; RAVLT, Rey Auditory Verbal Learning Test; BNT, Boston Naming Test; WCST, Wisconsin Card Sorting Test.

Comparison between the control group and aMCI patients revealed statistically significant differences in memory tasks (visual and verbal) for immediate and delayed recall, except for the immediate recall of Visual Reproduction test ([Table 4](#t4){ref-type="table"}).

###### 

Performance of controls and aMCI patients on the neuropsychological tests[\*](#TFN5){ref-type="table-fn"}.

  Tests                                     Mean±SD          *p*              
  ----------------------------------------- ---------------- ---------------- ---------
  Hooper                                    54.73 (14.87)    55.60 (17.54)    0.280
  Block Design (WAIS)                       10.50 (2.75)     11.66 (2.50)     0.074
  Rey Figure - Copy                         30.64 (6.86)     28.20 (6.60)     0.079
  Rey Figure - Memory                       11.02 (7.69)     2.51 (3.21)      \<0.001
  Trail Making - Part A (Time)              50.81 (31.99)    47.53 (15.23)    0.963
  Trail Making - Part B (Time)              113.72 (52.32)   110.25 (41.75)   0.986
  Logical Memory (WMS-R) - immediate        33.17 (5.51)     26.03 (8.14)     0.004
  Logical Memory (WMS-R) - 30\'             16.94 (8.53)     4.66 (5.33)      \<0.001
  Visual Reproduction (WMS-R) - immediate   28.82 (8.18)     22.66 (7.57)     0.023
  Visual Reproduction (WMS-R) - 30\'        13.64 (11.81)    1.23 (4.32)      \<0.001
  RAVLT - total                             40.08 (8.19)     28.60 (7.81)     \<0.001
  RAVLT - 30\'                              7.55 (3.24)      2.31 (1.74)      \<0.001
  BNT                                       45.02 (6.85)     42.71 (6.22)     0.138
  WCST (Categories)                         2.12 (1.54)      1.40 (1.34)      0.280
  Verbal Fluency - supermarket              20.81 (3.74)     18.80 (5.82)     0.034
  Raven\'s Colored Matrices                 26.90 (4.70)     26.50 (3.50)     0.831

Mann-Whitney Test; SD, standard deviation; MCI, Mild Cognitive Impairments; WAIS, Wechsler Adult Intelligence Scale; WMS-R, Wechsler Memory Scale - Revised; RAVLT, Rey Auditory Verbal Learning Test; BNT, Boston Naming Test; WCST, Wisconsin Card Sorting Test.

Statistically significant differences were observed between aMCI and AD patients on tasks of constructive and visuoperceptual abilities; attention; language and memory (except for delayed recall of Visual Reproduction test). No statistically significant differences in visual organization (measured by Hooper) and executive functions were noted (measured by WCST) ([Table 5](#t5){ref-type="table"}).

###### 

Performance of aMCI and AD patients on the neuropsychological tests[\*.](#TFN6){ref-type="table-fn"}

  Tests                                     Mean±SD          *p*              
  ----------------------------------------- ---------------- ---------------- ---------
  Hooper                                    64.02 (19.75)    55.60 (17.54)    0.041
  Block Design (WAIS)                       7.10 (3.74)      11.66 (2.50)     \<0.001
  Rey Figure - Copy                         21.39 (10.18)    28.20 (6.60)     0.004
  Rey Figure - Memory                       0.79 (2.69)      2.51 (3.21)      \<0.001
  Trail Making - Part A (Time)              92.76 (46.49)    47.53 (15.23)    \<0.001
  Trail Making - Part B (Time)              215.20 (83.89)   110.25 (41.75)   \<0.001
  Logical Memory (WMS-R) - immediate        13.78 (8.84)     26.03 (8.14)     \<0.001
  Logical Memory (WMS-R) - 30\'             1.35 (2.93)      4.66 (5.33)      \<0.001
  Visual Reproduction (WMS-R) - immediate   14.20 (7.33)     22.66 (7.57)     \<0.001
  Visual Reproduction (WMS-R) - 30\'        1.01 (3.95)      1.23 (4.32)      0.863
  RAVLT - total                             21.00 (7.91)     28.60 (7.81)     \<0.001
  RAVLT - 30\'                              1.06 (2.82)      2.31 (1.74)      \<0.001
  BNT                                       34.28 (8.93)     42.71 (6.22)     \<0.001
  WCST (Categories)                         0.43 (0.62)      1.40 (1.34)      0.116
  Verbal Fluency - supermarket              13.49 (4.74)     18.80 (5.82)     \<0.001
  Raven\'s Colored Matrices                 17.44 (6.22)     26.50 (3.50)     0.001

Mann-Whitney Test; SD, standard deviation; MCI, Mild Cognitive Impairments; WAIS, Wechsler Adult Intelligence Scale; WMS-R, Wechsler Memory Scale - Revised; RAVLT, Rey Auditory Verbal Learning Test; BNT, Boston Naming Test; WCST, Wisconsin Card Sorting Test.

Discussion
==========

Comparison of control group, aMCI and AD patients revealed a statistically significant difference in all tests applied. Our finding of differences among the groups for all cognitive functions evaluated is in line with results of several other studies. Boeve et al.^[@r29]^ demonstrated that MCI patients showed intermediate scores on memory tasks which lay between normal subjects and dementia patients. As expected, comparisons between control group and AD patients yielded statistically significant differences in all tests applied, where this result corroborates with characteristics of AD in that beyond memory impairments, other functions including attention, language, reasoning and visuospatial abilities are also damaged.^[@r30]^

Neuropsychological assessment was able to discriminate controls from aMCI patients through memory tasks, except for the immediate recall of Visual Reproduction. These findings may be explained since memory begins to decline early in the disease process while the most important evidence for aMCI is poor performance on memory tests^[@r3],[@r4],[@r31]-[@r34]^. Petersen et al.^[@r1]^ compared controls, MCI and mild AD patients by a neuropsychological assessment comprising the MMSE, WAIS-R, WMS-R, Dementia Rating Scale, Free and Cued Selective Reminding Test (FCSRT) and Rey Auditory Verbal Learning Test (RAVLT). The results showed similar performance on measures of general cognition between controls and MCI, but subjects with MCI were more significantly impaired on memory tasks. Perri et al.^[@r35]^ investigated different aspects of episodic long-term, short-term and implicit long-term memory in aMCI patients. Results showed normal short-term memory abilities, while the episodic long-term memory showed poorer results in aMCI than in controls. The authors affirmed that although some episodic memory functions were relatively well preserved, others appeared to have deteriorated to a level comparable to that of mild AD patients.

Statistically significant differences were observed between AD and aMCI patients in tasks of constructive and visuoperceptual abilities, attention, language, immediate and delayed recall verbal memory and immediate visual memory. The differences observed in other tasks beyond memory tests can be explained by the fact that AD patients present more severe disorders in many other cognitive domains such as attention, visuospatial abilities, language and complex motor tasks.^[@r1],[@r4],[@r36]^ Kramer et al.^[@r37]^ compared aMCI subjects, with presumably isolated memory impairment, with controls and very mild AD patients using a battery of neuropsychological tests. As expected, deficits in episodic memory were observed, but the aMCI group performed less well than controls yet better than the AD group on design fluency, category fluency, a set shifting task and the Stroop interference condition. Economou et al.^[@r38]^ compared patients with aMCI, mild AD and controls on nonepisodic memory measures. Working memory, processing speed, semantic fluency and complex motor tasks were significantly worse in the mild AD than the aMCI group. Rozzini et al.^[@r39]^ investigated the risk factors associated with conversion of aMCI to dementia of Alzheimer type. Subjects who converted to AD over time were classified as demented and subjects that remained unchanged, or became cognitively normal during follow-up were defined as Stable. After a one-year period, demented individuals presented worse performance on phonemic verbal fluency, Raven's colored matrices, Trail Making test A and B, and in Instrumental Activities of Daily Living than Stable subjects.

No statistically significant difference was observed between AD and aMCI patients in the delayed recall stage of the Visual Reproduction. Alescio-Lautier et al.^[@r40]^ found that both MCI and AD patients' had impairments on visual tasks. Griffith et al.^[@r41]^ showed that on the DRS, Initiation/Perseveration scores below 37 and Visual Reproduction Percent Retention scores below 26% correctly identified AD converters with 76.9% sensitivity and 91.7% specificity.

Many studies^[@r4],[@r29],[@r33]^ have shown that MCI subjects have a neuropsychological performance which lies between normal older individuals and demented patients. However, neuropsychological features for MCI classification are not yet well established. Studies^[@r42]-[@r44]^ have suggested that there is probably a continuum between aMCI and AD at early stages, which hampers discrimination among these groups, where the results of our study confirmed these difficulties. According to Nelson and O'Connor^[@r45]^ there is no consensus regarding an optimal test battery useful in the detection of MCI. Nonetheless, a well-constructed neuropsychological battery which comprises tests investigating specific aspects of memory complaints can detect subtle cognitive deficits that can easily be overlooked, particularly in patients with a high intellectual baseline. Winblad et al.^[@r2]^ suggested that individual slopes of decline in both functional and cognitive performance may be the best measures for diagnosing MCI. According to Celone et al.^[@r46]^ a longitudinal follow-up is necessary, however, to determine whether MCI subjects are indeed in the early phases of AD.

The present study confirmed that a well-constructed neuropsychological battery is important to reach differential diagnosis among controls, aMCI and AD patients, but in order to achieve diagnostic accuracy the scales must be used in conjunction with clinical features, functional activities investigation, biomarkers and neuroimaging measures.

In our sample, differences in age and schooling among the groups reached statistical significance. The limitation of this study was the absence of investigation of possible interference of these variables on performance in the neuropsychological tests.
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